首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   482篇
  免费   10篇
  国内免费   21篇
耳鼻咽喉   3篇
儿科学   2篇
妇产科学   3篇
基础医学   235篇
口腔科学   1篇
临床医学   18篇
内科学   52篇
皮肤病学   1篇
神经病学   3篇
特种医学   6篇
外科学   6篇
综合类   67篇
预防医学   78篇
眼科学   3篇
药学   20篇
肿瘤学   15篇
  2023年   1篇
  2022年   8篇
  2021年   9篇
  2020年   5篇
  2019年   3篇
  2018年   8篇
  2016年   7篇
  2015年   21篇
  2014年   27篇
  2013年   21篇
  2012年   17篇
  2011年   23篇
  2010年   21篇
  2009年   36篇
  2008年   27篇
  2007年   43篇
  2006年   31篇
  2005年   26篇
  2004年   34篇
  2003年   17篇
  2002年   7篇
  2001年   10篇
  2000年   10篇
  1999年   7篇
  1998年   5篇
  1997年   6篇
  1996年   6篇
  1995年   9篇
  1994年   9篇
  1993年   15篇
  1992年   2篇
  1991年   4篇
  1990年   3篇
  1989年   2篇
  1988年   1篇
  1987年   6篇
  1986年   3篇
  1985年   6篇
  1984年   4篇
  1983年   1篇
  1982年   1篇
  1981年   2篇
  1980年   6篇
  1979年   2篇
  1971年   1篇
排序方式: 共有513条查询结果,搜索用时 15 毫秒
11.
The influence of the DNA repair genePSO3 on photoactivated psoralen-induced meiotic recombination, gene conversion, reverse mutation, and on survival, was assayed in diploid strains ofSaccharomyces cerevisiae homozygous for the wild-type or thepso3-1 mutant allele. Sporulation was normal in thepso3-1 diploid. Wild-type and mutant strains had the same sensitivity to photoactivated monofunctional psoralen (3-CPs+UVA) in meiosis-uncommitted and meiosis-committed stages. The mutant showed higher sensitivity to photoactivated bifunctional psoralen (8-MOP+UVA) during all stages of the meiotic cycle. Mutation induction by 3-CPs+UVA or 8-MOP+UVA in meiosis-committed cells revealed no significant differences between wild-type and thepso3-1 mutant. The status of thePSO3 gene has no influence on the kinetics of induction of gene conversion and crossing-over after 3-CPs+UVA treatment in meiosis-committed cells: gene conversion was blocked while recombination was induced. After treatment with 8-MOP+UVA gene conversion was also blocked in both strains while crossing-over could only be observed in meiosis-committed wild-type cells.  相似文献   
12.
Site-specific homologous recombination mutagenesis in group B streptococci   总被引:3,自引:0,他引:3  
We describe the use of suicide vectors to generate site-specific mutations in group B streptococcus. This is accomplished by cloning gene-specific sequences into a temperature sensitive plasmid and selecting for clones which have undergone homologous recombination. The recombinan clones can be easily isolated by selecting for clones which have retained the antibiotic resistance markers that are present on the vector or cloned into the gene-specific sequences. To confirm the fidelity of the recombination events, PCR analysis is performed on chromosomal DNA isolated from the recombinant clones. Using this strategy, we have generated site- specific insertions in several capsule genes and have found that these insertions occurred as expected and that the mutations result in loss of capsule expression. In this report, we specifically detail the construction of cpsB mutants by single and double cross-over recombination and demonstrate that the resulting strains are acapsular.  相似文献   
13.
14.
Summary Southern hybridization of the total DNA of Agrocybe aegerita with cloned mitochondrial (mt) probes revealed a sequence homology between two distant mitochondrial restriction fragments. From the mtDNA restriction map and the distribution of restriction sites on the cross-hybridizing mitochondrial fragments, two copies of a large inverted repeated sequence (IR) of 3 kbp were located on the mitochondrial genome. These IR sequences divided the 80 kbp mtDNA into two singlecopy regions of 24 kbp (SSC) and 50 kbp (LSC). For the first time in higher fungi, this IR sequence has been shown to be involved in an intramolecular homologous recombinational event. Such a rearrangement led to an inversion of the orientation of the two unique-copy regions, without any change in mtDNA complexity. The location of the recombinational event was compared with previously reported plant and fungal mitochondrial rearrangements and the potential role of the IR sequence was discussed.  相似文献   
15.
《Vaccine》2022,40(48):6947-6955
BackgroundHuman papillomavirus (HPV) infections were the main cause of anogenital cancers and warts. HPV 6/11/16/18 vaccines provide protection against the high-risk types of HPV responsible for 70% of cervical cancers and 90% of genital warts. This randomized, blinded, non-inferiority phase III trial was to determine whether immunogenicity and tolerability would be non-inferior among women after receiving two novel 4- and 9-valent HPV vaccines (4vHPV, HPV 6/11/16/18; 9vHPV, HPV 6/11/16/18/31/33/45/52/58) compared with those receiving Gardasil 4 (4-valent).Methods1680 females between 20 and 45 years were randomized in a 2:1:1 ratio to 20–26, 27–35, or 36–45 y groups. Subjects then equally assigned to receive 4vHPV, 9vHPV or Gardasil 4 (control) vaccine at months 0, 2, and 6. End points included non-inferiority of HPV-6/11/16/18 antibodies for 4vHPV versus control, and 9vHPV versus control and safety. The immunogenicity non-inferiority was pre-defined as the lower bound of 95% confidence interval (CI) of seroconversion rate (SCR) difference > ?10% and the lower bound of 95% CI of geometric mean antibody titer (GMT) ratio > 0.5.ResultsAmong the three vaccine groups, more than 99% of the participants seroconverted to all 4 HPV types. The pre-specified statistical non-inferiority criterion for the immunogenicity hypothesis was met: all the lower bounds of 95% CIs on SCR differences exceeded ?10% for each vaccine HPV type and the corresponding lower bounds of 95% CIs for GMT ratios > 0.5. Across vaccination groups, the most common vaccination reaction were injection-site adverse events (AEs), including pain, swelling, and redness. General and serious AEs were similar in the three groups. There were no deaths.ConclusionsThis study demonstrated that the novel 4- and 9-valent HPV vaccination was highly immunogenic and generally well tolerated, both of which were non-inferior to Gardasil 4 in immunogenicity and safety.  相似文献   
16.
The expression of recombination activating gene (RAG) products, responsible for T cell receptor (TcR) gene rearrangement, is shut off during positive selection of thymocytes. The precise stage at which this down-regulation occurs remains somewhat controversial. We have analyzed RAG-1 expression in thymocytes of TcR transgenic mice carried on selecting versus non-selecting genetic backgrounds, both by in situ hybridization on thymus sections and by polymerase chain reaction amplification of RNA from sorted cells. The data from several transgenic lines indicate that RAG expression is already reduced in immature, cortical, CD4+CD8+ cells in the presence of positively selecting major histocompatibility complex molecules, although complete shut-off is not achieved until the mature, medullary, single-positive stage. This finding has practical and theoretical significance for studies on the mechanism of positive selection.  相似文献   
17.
乳腺癌(改良)根治术住院流程与平均住院日   总被引:1,自引:1,他引:0  
参照业务流程重组的理论与方法研究了乳腺癌根治术的住院流程。结果显示,该病种住院流程存在的主要问题有:诊疗服务的随意性过大,等待诊疗服务的时间过长,患者入院标准的掌握过松,对该病种往院注程进行重组,将在不影响医疗服务质量的前提下有效缩短平均住院日。  相似文献   
18.
重组Calpain蛋白的免疫原性及其诊断上的应用研究   总被引:1,自引:0,他引:1  
目的研究在大肠杆菌中表达的日本血吸虫Calpain蛋白的免疫原性及其在日本血吸虫诊断上的应用. 方法用重组Calpain蛋白免疫BALB/c小鼠,ELISA法测定特异性IgG抗体的动态变化及其IgG亚型(IgG1, IgG2a, IgG2b, IgG3)产生特征;同时用重组Calpain蛋白作为诊断抗原,粪检血吸虫病阳性患者血清作为一抗,肝吸虫阳性患者血清作为考核交叉反应血清. 结果重组Calpain抗原免疫小鼠后,产生了一个极高的抗Calpain特异性抗体,免疫4周后IgG类抗体达到高峰,与对照组鼠相比较,免疫鼠血清中IgG1, IgG2a, IgG2b特异性抗体也有显著性的上升; Calpain重组抗原血清诊断日本血吸虫和粪检的符合率为100%, 粪检阳性EPG低的个体抗Calpain抗体滴度高, EPG高的患者抗Calpain抗体滴度反而低, 与肝吸虫的交叉反应率为37%. 结论日本血吸虫Calpain是一个具有免疫原性的蛋白,能够激发宿主产生高水平的免疫球蛋白,能够敏感地测定日本血吸虫的感染, 说明Calpain可以发展成为日本血吸虫病的诊断抗原和日本血吸虫疫苗候选分子.  相似文献   
19.
The noroviruses are a major cause of outbreaks of gastroenteritis. The norovirus genotype “GII.e”, identified by ORF (Open Reading Frame) 1 nucleotide sequencing, appears to be an obligatory recombinant, in that no unique GII.e ORF 2 genotype has been identified. In 2012 GII.e norovirus became the predominant ORF 1 genotype in norovirus outbreaks in Victoria, Australia, and the current study documents changes in the ORF 1 region of GII.e norovirus since it first emerged in 2008, as well as in the ORF 2 genotypes associated with GII.e norovirus. GII.e norovirus underwent significant genetic change in ORF 1 between 2010 and 2012 and this genetic change corresponded to a significant increase in the prevalence of the virus. Nucleotide sequencing of the ORF 2 region of GII.e specimens showed that in 2008–2009, all the ORF 2 sequences corresponded to the GII.4 (2007) variant, in 2010 all the ORF 2 sequences corresponded to the GII.4 (2012-like) variant and in 2012 all the ORF 2 sequences corresponded to the GII.4 (2012) variant, the GII.4 (2012-like) variant, or the GII.4 (2009-like) variant. The evidence indicated that the development of the 2012 GII.e epidemic strains was due to evolutionary change rather than a novel recombination event. The results also support the notion that ORF 1 is critical in determining the virulence of a norovirus strain.  相似文献   
20.
目的:评价高龄病人手术后应用重组人生长激素(rh GH)对术后恢复的影响。方法:应用计算机检索Pubmed、Embase、中国生物医学文摘数据库(CBM)、维普中文期刊全文数据库中所有相关随机对照研究,按照一定标准对其筛选后进行质量评价。采用Rev Man 5.2软件进行统计和分析。结果:纳入10个随机对照研究,共计374例研究对象,其中术后应用rh GH的病人183例,对照组191例。分析结果表明,高龄病人术后应用rh GH能够1促进血清蛋白质合成,[WMD=5.60,95%CI(3.92,7.29),P0.01];促进清蛋白(ALB)水平恢复[WMD=3.79,95%CI(2.95,4.63),P0.01];促进转铁蛋白(TF)合成[WMD=0.52,95%CI(0.37,0.67),P0.000 01];促进前清蛋白(PA)合成[WMD=0.57,95%CI(0.09,1.06),P=0.02]。2促进血清免疫球蛋白水平恢复,结果分别为Ig A[WMD=0.48,95%CI(0.26,0.70),P0.01];Ig M[WMD=0.39,95%CI(0.26,0.52),P0.01];Ig G[WMD=2.31,95%CI(0.69,3.94),P0.01]。3减轻术后疲劳症状[WMD=-2.09,95%CI(-2.34,-1.85),P0.01]。结论:高龄病人术后应用rh GH可促进血清蛋白质合成,提高免疫功能,减轻疲劳综合征的症状,有利于病人康复。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号